HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-γc-/- (RAG-hu) mouse model

Retrovirology

Volumn 3, Issue , 2006, Pages

  Berges, Bradford K ^a   Wheat, William H ^a   Palmer, Brent E ^b   Connick, Elizabeth ^b   Akkina, Ramesh ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GREEN FLUORESCENT PROTEIN; RAG2 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; COCULTURE; CONTROLLED STUDY; EX VIVO STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN SITU HYBRIDIZATION; IN VIVO STUDY; MOUSE; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; REPORTER GENE; T CELL DEPLETION; VIREMIA; VIRUS IMMUNITY; VIRUS PATHOGENESIS; VIRUS STRAIN;

ANIMALS; ANTIGENS, CD34; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CYSTATIN C; CYSTATINS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV INFECTIONS; HIV-1; HUMANS; LIVER; MICE; MICE, INBRED BALB C; TRANSPLANTATION, HETEROLOGOUS; VIREMIA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33751003823     PISSN: 17424690     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-3-76     Document Type: Article

References (42)

1. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL: The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988, 241:1632-1639.
2. Mosier DE, Gulizia RJ, Baird SM, Wilson DB, Spector DH, Spector SA: Human immunodeficiency virus infection of human-PBL-SCID mice. Science 1991, 251:791-794.
3. Mosier DE: Human immunodeficiency virus infection of human cells transplanted to severe combined immunodeficient mice. Adv Immun 1996, 63:79-125.
4. Jamieson BD, Aldrovandi GM, Zack JA: The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS. Sem in Immun 1996, 8:215-221.
5. Mosier DE, Gulizia RJ, Baird SM, Spector S, Spector D, Kipps TJ, Fox RI, Carson DA, Cooper N, Richman DD, al.: Studies of HIV infection and the development of Epstein-Barr virus-related B cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency. Curr Top Micro Immun 1989, 152:195-199.
6. Mosier DE, Gulizia RJ, Maclsaac PD, Corey L, Greenberg PD: Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. Proc Natl Acad Sci USA 1993, 90:2443-2447.
7. Bonyhadi ML, Rabin L, Salimi S, Brown DA, Kosek J, McCune JM, Kaneshima H: HIV induces thymus depletion in vivo. Nature 1993, 363:728-732.
8. Aldrovandi GM, Feuer G, Gao L, Jamieson B, Kristeva M, Chen IS, Zack JA: The SCID-hu mouse as a model for HIV-1 infection. Nature 1993, 363:732-736.
9. Jamieson BD, Zack JA. In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus. J Virol 1998, 72:6520-6526.
10. McCune JM, Namikawa R, Shih CC, Rabin L, Kaneshima H: Suppression of HIV infection in AZT-treated SCID-hu mice. Science 1990, 247:564-566.
11. Stoddart CA, Moreno ME, Linquist-Stepps VD, Bare C, Bogan MR, Gobbi A, Buckheit RWJ, Bedard J, Rando RF, McCune JM: Antiviral activity of 2′-deoxy-3′-oxa-4′-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/ Liv mice. Antimicrob Agents Chemother 2000, 44:783-786.
12. Stanley SK, McCune JM, Kaneshima H, Justement JS, Sullivan M, Boone E, Baseler M, Adelsberger J, Bonyhadi M, Orenstein J: Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med 1993, 178:1151-1163.
13. Jamieson BD, Zack JA: Murine models for HIV disease. AIDS 1999, 13 Suppl A:11.
14. Mosier DE: Human xenograft models for virus infection. Virol 2000, 271:215-219.
15. Brooks DG, Hamer DH, Arlen PA, Gao L, Bristol G, Kitchen CM, Berger EA, Zack JA: Molecular characterization, reactivation, and depletion of latent HIV. Immunity 2003, 19:413-423.
16. Arlen PA, Brooks DG, Gao LY, Vatakis D, Brown HJ, Zack JA: Rapid expression of human immunodeficiency virus following activation of latently infected cells. J Virol 2006, 80:1599-1603.
17. Akkina RK, Rosenblatt JD, Campbell AG, Chen IS, Zack JA: Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse. Blood 1994, 84:1393-1398.
18. Banerjea A, Li MJ, Bauer G, Remling L, Lee NS, Rossi J, Akkina R: Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages. Mol Ther 2003, 8:62-71.
19. Bai J, Banda N, Lee NS, Rossi J, Akkina, R: RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model. Mol Ther 2002, 6:770-782.
20. Banerjea A, Li MJ, Remling L, Rossi J, Akkina R: Lentiviral transduction of Tar Decoy and CCR5 ribozyme into CD34+ progenitor cells and derivation of HIV-1 resistant T cells and macrophages. AIDS Res Ther 2004, 1:2.
21. Goldman JP, Blundell MP, Lopes L, Kinnon C, Di Santo JP, Thrasher AJ: Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. Br J Haematol 1998, 103:335-342.
22. Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, Kotb M, Gillies SD, King M, Mangada J, Greiner DL, Handgretinger R: Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immun 2005, 174:6477-6489.
23. Yahata T, Ando K, Nakamura Y, Ueyama Y, Shimamura K, Tamaoki N, Kato S, Hotta T: Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null mice. J Immun 2002, 169:204-209.
24. Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, Watanabe T, Akashi K, Shultz LD, Harada M: Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 2005, 106:1565-1573.
25. Hiramatsu H, Nishikomori R, Heike T, Ito M, Kobayashi K, Katamura K, Nakahata T: Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/ gammacnull mice model. Blood 2003, 102:873-880.
26. Kirberg J, Berns A, von Boehmer H: Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med 1997, 186:1269-1275.
27. Gimeno R, Weijer K, Voordouw A, Uittenbogaart CH, Legrand N, Alves NL, Wijnands E, Blom B, Spits H: Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2-/- gammac-/- mice: functional inactivation of p53 in developing T cells. Blood 2004, 104:3886-3893.
28. Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A, Manz MG: Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004, 304:104-107.
29. Macchiarini F, Manz MG, Palucka AK, Shultz LD: Humanized mice: are we there yet? J Exp Med 2005, 202:1307-1311.
30. Chicha L, Tussiwand R, Traggiai E, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A, Manz MG: Human Adaptive Immune System Rag2-/ -{gamma}c-/- Mice. Ann N Y Acad Sci 2005, 1044:236-243.
31. Weijer K, Uittenbogaart CH, Voordouw A, Couwenberg F, Seppen J, Blom B, Vyth-Dreese FA, Spits H: Intrathymic and extrathymic development of human plasmacytoid dendritic cell precursors in vivo. Blood 2002, 99:2752-2759.
32. Anderson JS, Bandi S, Kaufman DS, Akkina R: Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy. Retrovirology 2006, 3:24.
33. Hulstaert F, Hannet I, Deneys V, Munhyeshuli V, Reichert T, De Bruyere M, Strauss K: Age-related changes in human blood lymphocyte subpopulations. II. Varying kinetics of percentage and absolute count measurements. Clin Immun Immunopath 1994, 70:152-158.
34. Picchio GR, Gulizia RJ, Wehrly K, Chesebro B, Mosier DE: The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes. J Virol 1998, 72:2002-2009.
35. Gulizia RJ, Levy JA, Mosier DE: The envelope gp120 gene of human immunodeficiency virus type 1 determines the rate of CD4-positive T-cell depletion in SCID mice engrafted with human peripheral blood leukocytes. J Virol 1996, 70:4184-4187.
36. Watanabe S, Terashima K, Ohta S, Horibata S, Yajima M, Shiozawa Y, Dewan MZ, Yu Z, Ito M, Morio T, Shimizu N, Honda M, Yamamoto N: Hematopoietic stem cell-engrafted NOD/SCID/ IL2R{gamma}null mice develop human lymphoid system and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood 2006, (in press):.
37. Akkina R. Banerjea A, Bai J, Anderson J, Li Mj, Rossi J: sIRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS. Anticancer Research 2003, 23:1997-2005.
38. Anderson J, Banerjea A. Akkina R: Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance. Oligonudeotides 2003, 13:303-312.
39. Kutsch O, Benveniste EN, Shaw GM, Levy DN: Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency. J Virol 2002, 76:8776-8786.
40. Desire N, Dehee A, Schneider V, Jacomet C, Goujon C, Girard P, Rozenbaum W, Nicolas JC: Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. J Clin Microbiol 2001, 39:1303-1310.
41. Rouet F, Ekouevi DK, Chaix ML, Burgard M, Inwoley A, Tony TD, Danel C, Anglaret X, Leroy V, Msellati P, Dabis F, Rouzioux C: Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting. J Clin Microbiol 2005, 43:2709-2717.
42. Folkvord JM, Armon C, Connick E: Lymphoid follicles are sites of heightened human immunodeficiency virus type 1 (HIV-1) replication and reduced antiretroviral effector mechanisms. AIDS Res Hum Retroviruses 2005, 21:363-370.